co About Clinical Research Study | SCiStar Study AST‐OPC1

About SCiStar Study

SCiStar is a clinical research study evaluating the safety and activity of AST-OPC1 oligodendrocyte progenitor cells, an investigational agent for newly injured people with sensorimotor cervical (in the neck) spinal cord injury. This study has completed enrollment. The participants who have received AST-OPC1 will continue to be followed and Asterias Biotherapeutics will provide periodic study results updates at www.AsteriasBiotherapeutics.com.